Monday, 16 Jun 2025
Exclusive insights, data, and analysis for financial market experts.
Explore Now
Asia Business News
  • Home
  • Business
  • Finance
  • Technology
  • Medical
  • Politics
  • Breaking News
Subscribe
  • China
  • firm
  • Tariffs
  • Startup
  • Indian
  • market
  • Trump
  • South
  • Healthcare
  • Chinese
Asia Business NewsAsia Business News
Font ResizerAa
  • Read History
  • Environment
  • Business
  • Politics
  • Finance
  • Technology
Search
  • Pages
    • Home
    • Blog Index
    • Contact Us
    • Search Page
    • 404 Page
  • Personalized
    • Read History
  • Categories
    • Business
    • Politics
    • Technology
    • Environment
    • Finance
Have an existing account? Sign In
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Breaking News

Chemical maker that produces sharper X-ray images becomes India's newest billionaire

Asia Business News
Last updated: April 20, 2025 5:58 am
By Asia Business News
Share
3 Min Read
SHARE

Akshay Arora, chairman of Blue Jet Healthcare, is India’s latest billionaire.

from company

Shares in Blue Jet Healthcare, which makes specialty chemicals that enhance X-rays, CT scans and MRIs, have risen by nearly two-thirds in the past 12 months, making chairman Akshay Arora, 61, India’s latest billionaire. Multimillionaire with an estimated net worth of $1.1 billion.

Growing global demand for preventive healthcare and a rapidly aging population have boosted enthusiasm for Mumbai-based Blue Jet from the global medical imaging industry and investors.

Arora will take the company public in October 2023, retaining 86% of its shares. Two-thirds of Blue Jet’s annual revenue comes from the production of 75 chemicals called contrast chemicals. It is a $5.9 billion global industry expected to grow as demand for early diagnosis continues to grow.

In addition to these chemicals, 18% of Blue Jet’s sales come from artificial sweeteners, which are used in products ranging from beverages to food supplements. More than 13% of revenue comes from pharmaceutical intermediates, which, in addition to anti-cancer drugs, are also used in drugs against cardiovascular and central nervous system diseases.

“Growth in all three areas has been very strong for us,” Arora said in a phone interview Thursday.

From fiscal 2021 to fiscal 2024, the company’s annual revenue compound growth rate is 12.6%. 5% to 961 million rupees ($12 million).

The global comparative media sector is dominated by large companies such as Germany’s Bayer and Japan’s Daiichi Sankyo.

“If you look at the field of contrast chemistries, it’s a niche area,” Arora added. “The chemicals needed there are high-performance chemicals that need to be very precise so doctors can pinpoint the exact location on an MRI or CT scan. The barriers to entry are high, and we have multi-year contracts with customers.

The company was founded in 1968 by Arora’s late father Bansarilal Arora, initially to produce sweeteners. Arora holds a Master of Science in Organic Chemistry from the University of Mumbai and joined the company as a Director in 1983.

In 2000, he entered a niche market and eventually entered the league of the ultra-rich. He is also involved in the field of pharmaceutical intermediates.

Blue Jet looks set to be family-led going forward. Arora’s son Shiven studied business at Bond University in Australia and is now managing director, responsible for financial and strategic affairs.

TAGGED:BillionaireChemicalImagesIndia39smakernewestproducessharperXray
Share This Article
Email Copy Link Print
Previous Article India’s NDA leaders choose to combat with each other highly for Bihar, West Bengal surveys
Next Article No creases lah: SG’s biohacker boom

Subscribe Newsletter

Subscribe to our newsletter to get our newest articles instantly!
XFollow
InstagramFollow
LinkedInFollow
MediumFollow
RSS FeedFollow

Top News

Breaking News

Malaysia’s Sunway Team Chairman Jeffrey Cheah States The Very Best Is Yet To Find

June 9, 2025
Finance

Baidu to Deal Ernie Chatbot Free Of Charge Amidst DeepSeek Difficulty

March 19, 2025
Tech

Angkas gas up for PH competition with Grab

March 19, 2025
Medical

Many thanks to a brand-new collaboration with the area’s state college.

March 19, 2025

You May also Like

Breaking News

Titanic Successor’ Lastly Reveals Some Brand-new Gameplay

June 9, 2025
Breaking News

Gates Structure Opening Singapore Workplace To Strengthen Southeast Asia Collaborations

May 10, 2025
Medical

DeepCXR makes use of AI in evaluating upper body X-ray movies.

March 21, 2025
Breaking News

Guy Crazy. Rio Tinto Sheds Its fourth Chief Executive Officer In 12 Years

June 6, 2025
Show More
  • More News:
  • China
  • firm
  • Tariffs
  • Startup
  • Indian
  • market
  • Trump
  • South
  • Healthcare
  • Chinese
  • Hospital
  • Asia
  • Tech
  • President
  • launches
  • Funding
  • Global
  • India
  • Trade
  • Health
Asia Business News

Asia Business News (ISSN: 3079-8531) is a leading international business publication dedicated to delivering in-depth analysis, expert insights, and comprehensive coverage of economic trends, corporate developments, and market dynamics across the Asia-Pacific region and beyond. With a commitment to journalistic integrity and analytical rigor, Asia Business News serves as a trusted source of information for business leaders, policymakers, and investors seeking authoritative perspectives on global commerce, finance, and industry advancements.

Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Privacy Policy
  • Cookie Policy
  • Submit a Tip

© 2025 Asia Business News (ISSN: 3079-8531). All rights reserved.

This publication, including but not limited to all articles, reports, analyses, graphics, images, designs, and any other content, is the exclusive intellectual property of Asia Business News (ISSN: 3079-8531). Unauthorized reproduction, distribution, transmission, display, or publication of any portion of this content, in any form or by any means, including but not limited to electronic, mechanical, photocopying, recording, or any information storage and retrieval system, without the prior written consent of the publisher, is strictly prohibited.

Welcome to Foxiz
Username or Email Address
Password

Lost your password?